ERNA vs V
Eterna Therapeutics Inc (ERNA) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the ERNA and V stock pages for the full models.
Not investment advice.